Breaking News Instant updates and real-time market news.

FB

Facebook

$172.56

-12.53 (-6.77%)

09:32
03/20/18
03/20
09:32
03/20/18
09:32

Credit Suisse remains a buyer of Facebook

After media outlets reported data was harvested from Facebook through the use of an app where users were paid to take a personality test and agreed to have their data collected for "academic use," Credit Suisse analyst Stephen Ju notes that Facebook has already outlined its plans during Q3 earnings call to double headcount addressing user security, so he does not anticipate material change to OpEx guidance. The analyst believes the stock will be subject to further headline risk in the coming weeks as senior management is summoned to DC for hearings with lawmakers, but he remains a buyer. Ju reiterates an Outperform rating and $240 price target on the shares.

  • 22

    Mar

  • 11

    Apr

FB Facebook
$172.56

-12.53 (-6.77%)

03/20/18
BOFA
03/20/18
NO CHANGE
Target $265
BOFA
Buy
Facebook is 'oversold' with 'limited' near term catalysts, says BofA/Merrill
BofA/Merrill analyst Justin Post is keeping his Buy rating and $265 price target on Facebook, writing that while the stock is oversold, the compounding news flow raising privacy concerns is adding to risk. Post says that sentiment could remain pressured with looming General Data Protection Regulation enforcement coming into force in late Q2, adding that the company could use some added visibility on any impact in terms of user engagement and financial conditions. Longer term, the analyst believes that the current valuation makes the stock "compelling".
03/20/18
COWN
03/20/18
NO CHANGE
Target $220
COWN
Outperform
Facebook shares likely to remain under pressure, says Cowen
Cowen analyst John Blackledge said shares of Facebook are likely to remain under pressure as the story around the improper use of user data develops. In a research note to investors, Blackledge noted that Facebook ad executive Carolyn Everson addressed the press reports at Shoptalk, adding that Everson "reassured those in attendance, which includes both users and advertising partners, that its users privacy is of the upmost importance." According to Everson, Facebook believed that all the improperly obtained data was deleted, but "recently were made aware that this may not be the case." Blackledge has an Outperform rating and $220 price target on Facebook shares.
03/20/18
DBAB
03/20/18
NO CHANGE
DBAB
Buy
Facebook valuation 'extremely compelling' despite risks, says Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley sees three key risks for Facebook surrounding the Cambridge Analytica issue: ongoing headline risk that perpetuates a negative news cycle, direct risk around Facebook's perceived data security, and potential indirect impact from data regulations/legislation that ultimately curbs the company's ability to serve hyper targeted ads. The analyst, however, takes comfort in Facebook's "improving handling of other recent issues and its best-in-class overall execution." He sees a "large distance" between the current issues and any legislation that would curb Facebook's ad targeting in a meaningful way. As such, Facebook's valuation is "extremely compelling despite the increased risks," Walmsley tells investors in a research note.
03/20/18
MSCO
03/20/18
NO CHANGE
Target $230
MSCO
Overweight
Morgan Stanley answers 'top 4 investor questions' about Facebook
Morgan Stanley analyst Brian Nowak identified the top four questions he's heard from Facebook investors and outlined his answers in a new note. Addressing "What should Facebook do?", Nowak's take is that the company should become more assertive about the mistakes it has made and how it intends to fix them. On the question of "regulatory risk," he does believe the Cambridge Analytica news has increased Facebook's risk, which he contends only furthers the impetus to begin to take control of the public message, self-regulate and improve safeguards. On the question of "fundamental risk," Nowak said he does not see a fundamental risk to revenue or EPS as of now and he is not changing his FY18 and FY19 forecasts, though he adds that the "drumbeat of negative news and headlines" increases the risk that there is some user backlash and an "eventual" advertiser backlash. On the question of whether Facebook's multiple has bottomed, Nowak said "Yes, but this isn't new," as he noted that its multiple makes the stock cheaper than Alphabet (GOOGL), eBay (EBAY) and "many other assets" that are growing more slowly and/or don't have as much long-term monetization potential. Nowak maintains his Overweight rating and $230 price target on Facebook shares.

TODAY'S FREE FLY STORIES

ZLAB

Zai Lab

$19.93

-0.01 (-0.05%)

07:39
12/12/18
12/12
07:39
12/12/18
07:39
Hot Stocks
Zai Lab announces acceptance of Zejula NDA submission by NMPA »

Zai Lab announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$114.69

1.8 (1.59%)

07:39
12/12/18
12/12
07:39
12/12/18
07:39
Recommendations
Madrigal Pharmaceuticals analyst commentary  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHAK

Shake Shack

$46.73

-0.85 (-1.79%)

07:38
12/12/18
12/12
07:38
12/12/18
07:38
Recommendations
Shake Shack analyst commentary  »

Shake Shack price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

AEO

American Eagle

$19.03

-0.49 (-2.51%)

07:36
12/12/18
12/12
07:36
12/12/18
07:36
Recommendations
American Eagle analyst commentary  »

American Eagle shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAR

Marriott

$110.04

-0.78 (-0.70%)

07:36
12/12/18
12/12
07:36
12/12/18
07:36
Downgrade
Marriott rating change  »

Marriott downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$1.26

-0.04 (-3.08%)

07:35
12/12/18
12/12
07:35
12/12/18
07:35
Hot Stocks
MYnd Analytics appoints Patrick Herguth CEO, George Carpenter CIO »

MYnd Analytics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.58

-0.17 (-0.69%)

, T

AT&T

$29.70

-0.21 (-0.70%)

07:35
12/12/18
12/12
07:35
12/12/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$24.58

-0.17 (-0.69%)

T

AT&T

$29.70

-0.21 (-0.70%)

NIO

NIO Inc.

$7.05

0.03 (0.43%)

BX

Blackstone

$30.50

0.03 (0.10%)

KHC

Kraft Heinz

$48.38

0.1 (0.21%)

NBR

Nabors Industries

$2.82

0.12 (4.44%)

KKR

KKR

$20.92

-0.21 (-0.99%)

TROX

Tronox

$7.11

0.06 (0.85%)

MLCO

Melco Resorts & Entertainment

$17.36

0.35 (2.06%)

DLPH

Delphi Technologies

$16.07

0.26 (1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 18

    Dec

  • 30

    Jan

  • 12

    Feb

  • 20

    Mar

07:35
12/12/18
12/12
07:35
12/12/18
07:35
General news
U.S. MBA mortgage market index rose 1.6% »

U.S. MBA mortgage market…

AUDVF

Audi AG

$0.00

(0.00%)

07:34
12/12/18
12/12
07:34
12/12/18
07:34
Hot Stocks
Audi names interim CEO Bram Schot as chairman of the board »

The Supervisory Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTB

Cooper Tire

$30.71

0.12 (0.39%)

07:34
12/12/18
12/12
07:34
12/12/18
07:34
Hot Stocks
Cooper Tire, Sailun announce JV for new TBR tire plant in Vietnam »

Cooper Tire & Rubber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDS

Aridis Pharmaceuticals

$7.96

0.02 (0.25%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Hot Stocks
Aridis Pharmaceuticals enrolls first subject in Phase 1/2a lung infection trial »

Aridis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$85.72

-0.14 (-0.16%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Hot Stocks
Neurocrine says valbenazine did not meet primary endpoint in Phase IIb study »

Neurocrine Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$66.30

0.58 (0.88%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$33.95

1.285 (3.93%)

07:31
12/12/18
12/12
07:31
12/12/18
07:31
Conference/Events
Health Insurance Innovations to host analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

AQUA

Evoqua Water

$10.23

0.06 (0.59%)

07:31
12/12/18
12/12
07:31
12/12/18
07:31
Initiation
Evoqua Water initiated  »

Evoqua Water initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNTR

Pointer Telocation

$11.55

-0.25 (-2.12%)

07:30
12/12/18
12/12
07:30
12/12/18
07:30
Hot Stocks
Pointer Telocation and Pricol to form joint venture for telematics solution »

Pointer Telocation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRT

Federal Realty

$133.31

0.43 (0.32%)

07:30
12/12/18
12/12
07:30
12/12/18
07:30
Downgrade
Federal Realty rating change  »

Federal Realty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

GE

General Electric

$6.77

-0.15 (-2.17%)

, F

Ford

$8.54

0.015 (0.18%)

07:30
12/12/18
12/12
07:30
12/12/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GE

General Electric

$6.77

-0.15 (-2.17%)

F

Ford

$8.54

0.015 (0.18%)

SLB

Schlumberger

$41.24

-0.72 (-1.72%)

KO

Coca-Cola

$49.54

0.29 (0.59%)

ACB

Aurora Cannabis

$5.93

0.22 (3.85%)

FSLR

First Solar

$42.43

-0.79 (-1.83%)

UA

Under Armour

$20.87

-0.15 (-0.71%)

QSR

Restaurant Brands

$52.98

-0.81 (-1.51%)

GRMN

Garmin

$65.37

0.41 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 18

    Dec

  • 18

    Dec

  • 18

    Dec

  • 18

    Jan

  • 23

    Jan

  • 03

    Mar

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

H

Hyatt

$67.43

-1.41 (-2.05%)

07:29
12/12/18
12/12
07:29
12/12/18
07:29
Downgrade
Hyatt rating change  »

Hyatt downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HST

Host Hotels

$17.97

-0.13 (-0.72%)

07:28
12/12/18
12/12
07:28
12/12/18
07:28
Downgrade
Host Hotels rating change  »

Host Hotels downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEE

NextEra Energy

$183.05

0.33 (0.18%)

07:28
12/12/18
12/12
07:28
12/12/18
07:28
Recommendations
NextEra Energy analyst commentary  »

NextEra Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$85.72

-0.14 (-0.16%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Hot Stocks
Breaking Hot Stocks news story on Neurocrine »

Neurocrine trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Recommendations
Tesla analyst commentary  »

Tesla poised to exceed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LULU

Lululemon

$116.67

1.66 (1.44%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Upgrade
Lululemon rating change  »

Citi upgrades Lululemon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

UAA

Under Armour

$22.14

-0.25 (-1.12%)

07:25
12/12/18
12/12
07:25
12/12/18
07:25
Conference/Events
Under Armour to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 14

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.